Skip to main content

Table 1 Baseline characteristics of the patients (N = 1660)

From: Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

Characteristic

n (% of total)*

Gender

   Male

1183 (71.3%)

   Female

430 (25.9%)

   Not specified

47 (2.8%)

Ethnicity

   White

1116 (67.2%)

   Mestizo

300 (18.1%)

   Black

154 (9.3%)

   Chinese

8 (0.5%)

   Not specified

82 (4.9%)

Age (yr) total (183 not specified)

61.6 ± 13.0

Onset-infusion time (hours)

4.9 ± 3.7

Previous SK

   < 1 year

5 (0.3%)

   > 1 year

9 (0.5%)

Concomitant therapy

   Aspirin

1341 (80.8%)

   Beta-blockers

943 (56.8%)

   Nitrosorbide

258 (15.5%)

   Lidocaine

66 (3.9%)

   Pentaerythritol tetranitrate

45 (2.7%)

   Others

641 (38.6%)

  1. *Continuous variables are presented as Mean ± SD